Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 72

1.

A Real-World Observational Study Examining the Impact of Aclidinium Bromide Therapy on the Quality of Life, Symptoms, and Activity Impairment of Patients with Chronic Obstructive Pulmonary Disease: The Greek ON-AIR Study.

Kostikas K, Vassilakopoulos TI, Tzanakis N, Konstantinidis AK, Kosmas EN, Papiris S, Steiropoulos P, Manali ED, Michaelides SA, Daskos G.

Int J Chron Obstruct Pulmon Dis. 2020 Mar 6;15:515-526. doi: 10.2147/COPD.S239044. eCollection 2020.

2.

First heterozygous NOP10 mutation in Familial Pulmonary Fibrosis.

Kannengiesser C, Manali ED, Revy P, Callebaut I, Ba I, Borgel A, Oudin C, Haritou A, Kolilekas L, Malagari K, Borie R, Lainey E, Boileau C, Crestani B, Papiris SA.

Eur Respir J. 2020 Mar 5. pii: 1902465. doi: 10.1183/13993003.02465-2019. [Epub ahead of print] No abstract available.

PMID:
32139460
3.

Inhaled GM-CSF for Pulmonary Alveolar Proteinosis.

Papiris SA, Griese M, Manali ED.

N Engl J Med. 2020 Jan 9;382(2):197. doi: 10.1056/NEJMc1914606. No abstract available.

PMID:
31914249
4.

Prospective evAluatIon foR inhalation devices in Greek patients with COPD and asthma: The PAIR study.

Karampitsakos T, Hillas G, Zervas E, Bakakos P, Stratakos G, Dimakou K, Manali E, Bouros D, Papiris S, Tzouvelekis A; PAIR study investigators.

Pulm Pharmacol Ther. 2020 Feb;60:101882. doi: 10.1016/j.pupt.2019.101882. Epub 2019 Dec 24.

PMID:
31881275
5.

Lung cancer in patients with Idiopathic Pulmonary Fibrosis. A retrospective multicenter study in Greece.

Tzouvelekis A, Karampitsakos T, Gomatou G, Bouros E, Tzilas V, Manali E, Tomos I, Trachalaki A, Kolilekas L, Korbila I, Tomos P, Chrysikos S, Gaga M, Daniil Z, Bardaka F, Papanikolaou IC, Euthymiou C, Papakosta D, Steiropoulos P, Ntolios P, Tringidou R, Papiris S, Antoniou K, Bouros D.

Pulm Pharmacol Ther. 2020 Feb;60:101880. doi: 10.1016/j.pupt.2019.101880. Epub 2019 Dec 23.

PMID:
31874284
6.

Idiopathic Pulmonary Fibrosis: Best Practice in Monitoring and Managing a Relentless Fibrotic Disease.

Wuyts WA, Wijsenbeek M, Bondue B, Bouros D, Bresser P, Robalo Cordeiro C, Hilberg O, Magnusson J, Manali ED, Morais A, Papiris S, Shaker S, Veltkamp M, Bendstrup E.

Respiration. 2020;99(1):73-82. doi: 10.1159/000504763. Epub 2019 Dec 12. Review.

7.

Emerging phenotypes of sarcoidosis based on 18F-FDG PET/CT: a hierarchical cluster analysis.

Papiris SA, Georgakopoulos A, Papaioannou AI, Pianou N, Kallergi M, Kelekis NL, Gialafos H, Manali ED, Chatziioannou S.

Expert Rev Respir Med. 2020 Feb;14(2):229-238. doi: 10.1080/17476348.2020.1684902. Epub 2019 Oct 29.

PMID:
31647341
8.

18F-FDG PET/CT in Pulmonary Sarcoidosis:Quantifying Inflammation by the TLG index.

Papiris SA, Manali ED, Pianou NK, Kallergi M, Papaioannou AI, Georgakopoulos A, Malagari K, Kelekis NL, Gialafos H, Chatziioannou S.

Expert Rev Respir Med. 2020 Jan;14(1):103-110. doi: 10.1080/17476348.2020.1682997. Epub 2019 Oct 24.

PMID:
31626563
9.

Mycophenolate mofetil as an alternative treatment in sarcoidosis.

Papiris S, Stagaki E, Papadaki G, Kolilekas L, Korbila I, Apollonatou V, Kallieri M, Gialafos H, Chatziioannou S, Papaioannou AI, Manali ED.

Pulm Pharmacol Ther. 2019 Oct;58:101840. doi: 10.1016/j.pupt.2019.101840. Epub 2019 Sep 10.

PMID:
31518648
10.

Pulmonary Fibrosis in Children.

Nathan N, Sileo C, Thouvenin G, Berdah L, Delestrain C, Manali E, Papiris S, Léger PL, Pointe HDL, l'Hermine AC, Clement A.

J Clin Med. 2019 Aug 26;8(9). pii: E1312. doi: 10.3390/jcm8091312. Review.

11.

Myelodysplastic syndromes and idiopathic pulmonary fibrosis: a dangerous liaison.

Papiris SA, Tsirigotis P, Kannengiesser C, Kolilekas L, Gkirkas K, Papaioannou AI, Revy P, Giouleka P, Papadaki G, Kagouridis K, Pappa V, Borie R, Boileau C, Bouros D, Crestani B, Manali ED.

Respir Res. 2019 Aug 13;20(1):182. doi: 10.1186/s12931-019-1151-6.

12.

Bi-allelic missense ABCA3 mutations in a patient with childhood ILD who reached adulthood.

Manali ED, Legendre M, Nathan N, Kannengiesser C, Coulomb-L'Hermine A, Tsiligiannis T, Tomos P, Griese M, Borie R, Clement A, Amselem S, Crestani B, Papiris SA.

ERJ Open Res. 2019 Jul 22;5(3). pii: 00066-2019. doi: 10.1183/23120541.00066-2019. eCollection 2019 Jul.

13.

MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease.

Juge PA, Lee JS, Ebstein E, Furukawa H, Dobrinskikh E, Gazal S, Kannengiesser C, Ottaviani S, Oka S, Tohma S, Tsuchiya N, Rojas-Serrano J, González-Pérez MI, Mejía M, Buendía-Roldán I, Falfán-Valencia R, Ambrocio-Ortiz E, Manali E, Papiris SA, Karageorgas T, Boumpas D, Antoniou K, van Moorsel CHM, van der Vis J, de Man YA, Grutters JC, Wang Y, Borie R, Wemeau-Stervinou L, Wallaert B, Flipo RM, Nunes H, Valeyre D, Saidenberg-Kermanac'h N, Boissier MC, Marchand-Adam S, Frazier A, Richette P, Allanore Y, Sibilia J, Dromer C, Richez C, Schaeverbeke T, Lioté H, Thabut G, Nathan N, Amselem S, Soubrier M, Cottin V, Clément A, Deane K, Walts AD, Fingerlin T, Fischer A, Ryu JH, Matteson EL, Niewold TB, Assayag D, Gross A, Wolters P, Schwarz MI, Holers M, Solomon JJ, Doyle T, Rosas IO, Blauwendraat C, Nalls MA, Debray MP, Boileau C, Crestani B, Schwartz DA, Dieudé P.

N Engl J Med. 2018 Dec 6;379(23):2209-2219. doi: 10.1056/NEJMoa1801562. Epub 2018 Oct 20.

14.

Safety and efficacy of pirfenidone in patients carrying telomerase complex mutation.

Justet A, Thabut G, Manali E, Molina Molina M, Kannengiesser C, Cadranel J, Cottin V, Gondouin A, Nunes H, Magois E, Tromeur C, Prevot G, Papiris S, Marchand-Adam S, Gamez AS, Reynaud-Gaubert M, Wemeau L, Crestani B, Borie R.

Eur Respir J. 2018 Mar 15;51(3). pii: 1701875. doi: 10.1183/13993003.01875-2017. Print 2018 Mar. No abstract available.

15.

Ability of using different dry powder inhalers during COPD exacerbations.

Papaioannou AI, Herodotou Y, Tomos I, Apollonatou V, Verykokou G, Papathanasiou E, Manali ED, Loukides S, Papiris SA.

Pulm Pharmacol Ther. 2018 Feb;48:211-216. doi: 10.1016/j.pupt.2017.12.007. Epub 2017 Dec 19.

PMID:
29277688
16.

High levels of IL-6 and IL-8 characterize early-on idiopathic pulmonary fibrosis acute exacerbations.

Papiris SA, Tomos IP, Karakatsani A, Spathis A, Korbila I, Analitis A, Kolilekas L, Kagouridis K, Loukides S, Karakitsos P, Manali ED.

Cytokine. 2018 Feb;102:168-172. doi: 10.1016/j.cyto.2017.08.019. Epub 2017 Aug 25.

PMID:
28847533
17.

Exhaled Breath Condensate Acidification Occurs During Surgery for Abdominal Cancer.

Mahairidou A, Rodopoulou S, Tomos I, Maratou E, Manali E, Raptakis T, Papiris SA, Karakatsani A.

Anticancer Res. 2017 Jun;37(6):3315-3321.

PMID:
28551684
18.

Massive hemoptysis in a patient with pulmonary embolism, a real therapeutic conundrum.

Herodotou Y, Papaioannou AI, Karakatsani A, Reppas L, Manali ED, Apollonatou V, Tomos I, Brountzos E, Papiris S.

Respir Med Case Rep. 2017 Feb 28;20:179-183. doi: 10.1016/j.rmcr.2017.02.013. eCollection 2017.

19.

Extracellular matrix remodeling in idiopathic pulmonary fibrosis. It is the 'bed' that counts and not 'the sleepers'.

Tomos IP, Tzouvelekis A, Aidinis V, Manali ED, Bouros E, Bouros D, Papiris SA.

Expert Rev Respir Med. 2017 Apr;11(4):299-309. doi: 10.1080/17476348.2017.1300533. Epub 2017 Mar 8. Review.

PMID:
28274188
20.

The New Idiopathic Pulmonary Fibrosis Acute Exacerbations Document: One Step Ahead but Still Suspended in the Air.

Papiris SA, Kagouridis K, Kolilekas L, Karakatsani A, Korbila I, Giouleka P, Papadaki G, Maniati M, Bouros D, Manali ED.

Am J Respir Crit Care Med. 2017 Jan 15;195(2):267-269. doi: 10.1164/rccm.201607-1426LE. No abstract available.

PMID:
28084826
21.

Unilateral hypertransparency on chest radiograph: the congenital Poland Syndrome.

Tomos I, Papaioannou AI, Vlami A, Apollonatou V, Manali ED, Papiris SA.

Adv Respir Med. 2016;84(6):342-343. doi: 10.5603/ARM.2016.0045.

22.

Combined pulmonary fibrosis and emphysema: The many aspects of a cohabitation contract.

Papaioannou AI, Kostikas K, Manali ED, Papadaki G, Roussou A, Kolilekas L, Borie R, Bouros D, Papiris SA.

Respir Med. 2016 Aug;117:14-26. doi: 10.1016/j.rmed.2016.05.005. Epub 2016 May 7. Review.

23.

Celebrating Two Centuries since the Invention of the Stethoscope. René Théophile Hyacinthe Laënnec (1781-1826).

Tomos I, Karakatsani A, Manali ED, Papiris SA.

Ann Am Thorac Soc. 2016 Oct;13(10):1667-1670.

PMID:
27467020
24.

Serum Levels of Surfactant Proteins in Patients with Combined Pulmonary Fibrosis and Emphysema (CPFE).

Papaioannou AI, Kostikas K, Manali ED, Papadaki G, Roussou A, Spathis A, Mazioti A, Tomos I, Papanikolaou I, Loukides S, Chainis K, Karakitsos P, Griese M, Papiris S.

PLoS One. 2016 Jun 23;11(6):e0157789. doi: 10.1371/journal.pone.0157789. eCollection 2016.

25.

Diffuse Idiopathic Skeletal Hyperostosis (DISH) and non small cell lung cancer: case presentation and review of the literature.

Tomos I, Vlami A, Karakatsani A, Korbila I, Manali ED, Papiris SA.

Pneumonol Alergol Pol. 2016;84(2):116-8. doi: 10.5603/PiAP.2016.0010. Review.

26.

Pharmacological management of IPF.

Borie R, Justet A, Beltramo G, Manali ED, Pradère P, Spagnolo P, Crestani B.

Respirology. 2016 May;21(4):615-25. doi: 10.1111/resp.12778. Epub 2016 Apr 12. Review.

27.

Acute Respiratory Events in Connective Tissue Disorders.

Papiris SA, Manali ED, Kolilekas L, Kagouridis K, Maniati M, Filippatos G, Bouros D.

Respiration. 2016;91(3):181-201. doi: 10.1159/000444535. Epub 2016 Mar 4. Review.

28.

Survival in Idiopathic pulmonary fibrosis acute exacerbations: the non-steroid approach.

Papiris SA, Kagouridis K, Kolilekas L, Papaioannou AI, Roussou A, Triantafillidou C, Baou K, Malagari K, Argentos S, Kotanidou A, Karakatsani A, Manali ED.

BMC Pulm Med. 2015 Dec 14;15:162. doi: 10.1186/s12890-015-0146-4.

29.

The Ring of the Aortas: The Silent Variation.

Tomos I, Vlami A, Korbila I, Manali ED, Karakatsani A, Papiris SA.

Ann Thorac Surg. 2015 Dec;100(6):2371. doi: 10.1016/j.athoracsur.2015.08.065. No abstract available.

PMID:
26652542
30.

Cardiovascular risk in pulmonary alveolar proteinosis.

Manali ED, Papadaki G, Konstantonis D, Tsangaris I, Papaioannou AI, Kolilekas L, Schams A, Kagouridis K, Karakatsani A, Orfanos S, Griese M, Papiris SA.

Expert Rev Respir Med. 2016 Feb;10(2):235-40. doi: 10.1586/17476348.2016.1116389. Epub 2015 Nov 27.

PMID:
26558331
31.

Surfactant Proteins in Smoking-Related Lung Disease.

Papaioannou AI, Papiris S, Papadaki G, Manali ED, Roussou A, Spathis A, Karakitsos P, Kostikas K.

Curr Top Med Chem. 2016;16(14):1574-81. Review.

PMID:
26420367
32.

"Luck's always to blame": silent wounds of a penetrating gunshot trauma sustained 20 years ago.

Tomos I, Manali ED, Argentos S, Raptakis T, Papiris SA.

Pneumonol Alergol Pol. 2015;83(5):392-3. doi: 10.5603/PiAP.2015.0063.

33.

Challenges in the classification of fibrotic ILD: Patient case 1.

Manali ED.

Sarcoidosis Vasc Diffuse Lung Dis. 2015 Aug 3;32 Suppl 1:10-2.

PMID:
26237437
34.

Challenges in the classification of fibrotic ILD.

Bendstrup E, Maher TM, Manali ED, Wijsenbeek M.

Sarcoidosis Vasc Diffuse Lung Dis. 2015 Aug 3;32 Suppl 1:4-9. Review.

PMID:
26237436
35.

Investigation of Lung Involvement in Connective Tissue Disorders.

Papiris SA, Manali ED, Kolilekas L, Kagouridis K, Maniati M, Borie R, Pradere P, Crestani B, Bouros D.

Respiration. 2015;90(1):2-24. doi: 10.1159/000435817. Epub 2015 Jun 26. Review.

36.

Pulmonary alveolar proteinosis: time to shift?

Papiris SA, Tsirigotis P, Kolilekas L, Papadaki G, Papaioannou AI, Triantafillidou C, Papaporfyriou A, Karakatsani A, Kagouridis K, Griese M, Manali ED.

Expert Rev Respir Med. 2015 Jun;9(3):337-49. doi: 10.1586/17476348.2015.1035259. Epub 2015 Apr 12. Review.

PMID:
25864717
37.

Relationship between tumor necrosis factor-α (TNFA) gene polymorphisms and cardiac sarcoidosis.

Gialafos E, Triposkiadis F, Kouranos V, Rapti A, Kosmas I, Manali E, Giamouzis G, Elezoglou A, Peros I, Anagnostopoulou O, Koulouris N, Gazouli M.

In Vivo. 2014 Nov-Dec;28(6):1125-9.

PMID:
25398810
38.

Long-term inhaled granulocyte macrophage-colony-stimulating factor in autoimmune pulmonary alveolar proteinosis: effectiveness, safety, and lowest effective dose.

Papiris SA, Tsirigotis P, Kolilekas L, Papadaki G, Papaioannou AI, Triantafillidou C, Papaporfyriou A, Karakatsani A, Kagouridis K, Griese M, Manali ED.

Clin Drug Investig. 2014 Aug;34(8):553-64. doi: 10.1007/s40261-014-0208-z.

PMID:
24890235
39.

Heart rate recovery post 6-minute walking test in obstructive sleep apnea: cycle ergometry versus 6-minute walking test in OSA patients.

Cholidou KG, Manali ED, Kapsimalis F, Kostakis ID, Vougas K, Simoes D, Markozannes E, Vogiatzis I, Bakakos P, Koulouris N, Alchanatis M.

Clin Res Cardiol. 2014 Oct;103(10):805-15. doi: 10.1007/s00392-014-0721-3. Epub 2014 May 13.

PMID:
24820928
40.

Idiopathic pulmonary fibrosis acute exacerbations: where are we now?

Papiris SA, Kagouridis K, Kolilekas L, Bouros D, Manali ED.

Expert Rev Respir Med. 2014 Jun;8(3):271-3. doi: 10.1586/17476348.2014.896206. Epub 2014 Mar 22.

PMID:
24655104
41.

Myocardial stress perfusion-fibrosis imaging pattern in sarcoidosis, assessed by cardiovascular magnetic resonance imaging.

Mavrogeni S, Kouranos V, Sfikakis PP, Bratis K, Kitas GD, Manali E, Perros E, Vlasis K, Rapti A, Koulouris N, van Wijk K, Hautemann D, Reiber JH, Kolovou G, Tzelepis GE, Gialafos E.

Int J Cardiol. 2014 Mar 15;172(2):501-3. doi: 10.1016/j.ijcard.2014.01.006. Epub 2014 Jan 16. No abstract available.

PMID:
24476697
42.

The Role of Cardiopulmonary Exercise Test in IPF Prognosis.

Triantafillidou C, Manali E, Lyberopoulos P, Kolilekas L, Kagouridis K, Gyftopoulos S, Vougas K, Kotanidou A, Alchanatis M, Karakatsani A, Papiris SA.

Pulm Med. 2013;2013:514817. doi: 10.1155/2013/514817. Epub 2013 Oct 31.

43.

Treating CTDs related fibrotic ILDs by immunosuppressants: "facts and faults".

Papiris SA, Kagouridis K, Papadaki G, Kolilekas L, Manali ED.

Lung. 2014 Apr;192(2):221-3. doi: 10.1007/s00408-013-9532-y. Epub 2013 Nov 12.

PMID:
24217988
44.

Sleep oxygen desaturation predicts survival in idiopathic pulmonary fibrosis.

Kolilekas L, Manali E, Vlami KA, Lyberopoulos P, Triantafillidou C, Kagouridis K, Baou K, Gyftopoulos S, Vougas KN, Karakatsani A, Alchanatis M, Papiris S.

J Clin Sleep Med. 2013 Jun 15;9(6):593-601. doi: 10.5664/jcsm.2758.

45.

Bronchiolitis: adopting a unifying definition and a comprehensive etiological classification.

Papiris SA, Malagari K, Manali ED, Kolilekas L, Triantafillidou C, Baou K, Rontogianni D, Bouros D, Kagouridis K.

Expert Rev Respir Med. 2013 Jun;7(3):289-306. doi: 10.1586/ers.13.21. Review.

PMID:
23734650
46.

Depression, physical activity, energy consumption, and quality of life in OSA patients before and after CPAP treatment.

Diamanti C, Manali E, Ginieri-Coccossis M, Vougas K, Cholidou K, Markozannes E, Bakakos P, Liappas I, Alchanatis M.

Sleep Breath. 2013 Dec;17(4):1159-68. doi: 10.1007/s11325-013-0815-6. Epub 2013 Feb 6.

PMID:
23386373
47.

Calprotectin: a protein related to cardiovascular risk in adult patients with obstructive sleep apnea.

Cholidou KG, Kostakis ID, Manali ED, Perrea D, Margeli A, Vougas K, Markozannes E, Koulouris N, Alchanatis M.

Cytokine. 2013 Mar;61(3):917-23. doi: 10.1016/j.cyto.2012.12.014. Epub 2013 Jan 29.

PMID:
23375123
48.

Combined pulmonary fibrosis and emphysema.

Papiris SA, Triantafillidou C, Manali ED, Kolilekas L, Baou K, Kagouridis K, Bouros D.

Expert Rev Respir Med. 2013 Feb;7(1):19-31; quiz 32. doi: 10.1586/ers.12.80. Review.

PMID:
23362797
49.

Pirfenidone treatment in idiopathic pulmonary fibrosis: too much of a great expectation?

Papiris SA, Kagouridis K, Kolilekas L, Triantafillidou C, Tsangaris I, Manali ED.

Eur Respir J. 2012 Sep;40(3):794-5. doi: 10.1183/09031936.00114311. No abstract available.

50.

Steroids in idiopathic pulmonary fibrosis acute exacerbation: defenders or killers?

Papiris SA, Manali ED, Kolilekas L, Triantafillidou C, Tsangaris I, Kagouridis K.

Am J Respir Crit Care Med. 2012 Mar 1;185(5):587-8. No abstract available.

PMID:
22383571

Supplemental Content

Loading ...
Support Center